We are live on ! Find out more
VIVO

Meridian Bioscience Inc

Delisted

VIVO was delisted on the 30th of January, 2023.

203 hedge funds and large institutions have $1.29B invested in Meridian Bioscience Inc in 2022 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 59 increasing their positions, 65 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more call options, than puts

Call options by funds: $3.7M | Put options by funds: $2.12M

4% less capital invested

Capital invested by funds: $1.35B → $1.29B (-$57.8M)

9% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 65

6% less funds holding

Funds holding: 216203 (-13)

20% less first-time investments, than exits

New positions opened: 49 | Existing positions closed: 61

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

Holders
203
Holders Change
-13
Holders Change %
-6.02%
% of All Funds
3.5%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.05%
New
49
Increased
59
Reduced
65
Closed
61
Calls
$3.7M
Puts
$2.12M
Net Calls
+$1.58M
Net Calls Change
-$3.26M
Name Holding Trade Value Shares
Change
Change in
Stake
Canada Pension Plan Investment Board
51
Canada Pension Plan Investment Board
Ontario, Canada
$3.24M +$3.33M +102,800 New
RhumbLine Advisers
52
RhumbLine Advisers
Massachusetts
$3M -$626K -19,347 -17%
New York State Teachers Retirement System (NYSTRS)
53
New York State Teachers Retirement System (NYSTRS)
New York
$2.71M
Wells Fargo
54
Wells Fargo
California
$2.62M -$7.05M -217,626 -72%
E
55
Ergoteles
New York
$2.61M +$2.68M +82,888 New
Public Sector Pension Investment Board (PSP Investments)
56
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.53M -$15.3K -474 -0.6%
HA
57
Havens Advisors
New York
$2.43M +$2.49M +77,000 New
PCM
58
Prelude Capital Management
New York
$2.4M +$2.46M +76,028 New
Bank of America
59
Bank of America
North Carolina
$2.32M -$293K -9,055 -11%
VIA
60
Vident Investment Advisory
Georgia
$2.23M +$2.29M +70,694 New
BA
61
Bridgewater Associates
Connecticut
$2.15M -$9K -278 -0.4%
ETM
62
Euclidean Technologies Management
Washington
$1.99M -$324K -10,000 -14%
WG
63
Winton Group
United Kingdom
$1.98M +$1.54M +47,679 +316%
American Century Companies
64
American Century Companies
Missouri
$1.96M -$10.3K -317 -0.5%
OR
65
Olympiad Research
Connecticut
$1.92M +$1.97M +60,901 New
ETC
66
Exchange Traded Concepts
Oklahoma
$1.74M +$487K +15,048 +38%
California State Teachers Retirement System (CalSTRS)
67
California State Teachers Retirement System (CalSTRS)
California
$1.72M -$32.1K -992 -2%
Canada Life
68
Canada Life
Manitoba, Canada
$1.71M +$358K +11,059 +26%
UBS AM
69
UBS AM
Illinois
$1.7M +$463K +14,284 +36%
MCM
70
Moore Capital Management
New York
$1.6M +$1.64M +50,636 New
Two Sigma Advisers
71
Two Sigma Advisers
New York
$1.54M -$2.53M -78,100 -61%
Prudential Financial
72
Prudential Financial
New Jersey
$1.52M -$371K -11,470 -19%
HSA
73
Hussman Strategic Advisors
Maryland
$1.47M -$502K -15,500 -25%
Thrivent Financial for Lutherans
74
Thrivent Financial for Lutherans
Minnesota
$1.43M +$78.1K +2,412 +6%
Victory Capital Management
75
Victory Capital Management
Texas
$1.39M -$3.52M -108,816 -71%

VIVO Hedge Fund Activity: Q3 2022 in Review

203 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2022, worth a combined $1.29B — down 4.3% from $1.35B a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of VIVO and 49 opened new positions — a net loss of 12 holders — while 65 trimmed existing stakes and 59 added.

The largest buyer was Magnetar Financial, opening a new position worth an estimated $72.8M. The largest seller was EARNEST Partners, cutting an estimated $115M.

  • 203 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2022, down from 216 in Q2 2022.
  • Funds reported $1.29B of Meridian Bioscience Inc stock for Q3 2022, down 4.3% quarter-over-quarter.
  • 49 funds opened new Meridian Bioscience Inc positions in Q3 2022 and 61 closed out, a net change of -12 holders.
  • The largest Meridian Bioscience Inc buyer in Q3 2022 was Magnetar Financial, an estimated $72.8M added.
  • The largest Meridian Bioscience Inc seller in Q3 2022 was EARNEST Partners, an estimated $115M sold.

Based on aggregated 13F filings for Q3 2022.